Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Merck Serono supports call for global schistosomiasis elimination

Merck Serono supports call for global schistosomiasis elimination

23rd May 2014

Merck Serono's parent company Merck KGgA has proposed the creation of a global alliance centred on the elimination of the tropical disease schistosomiasis.

The company wishes to see companies and public bodies allying with the World Health Organization (WHO) in a new worldwide partnership, of which Merck KGaA will be a founding member. This would focus efforts to address remaining gaps and challenges to meet the elimination target.

Schistosomiasis is a worm disease that is prevalent in Africa and other underprivileged regions. It is the second most prevalent parasitic disease in tropical countries after malaria, infecting more than 240 million people and killing around 200,000 each year.

Merck Serono is responsible for providing supplies of the drug praziquantel, which is well tolerated and the most effective treatment to date for schistosomiasis, to the WHO.

Stefan Oschmann, member of the executive board of Merck KGaA and chief executive officer for pharmaceuticals, said: "We see this initiative as a major development. This alliance will allow the different constituencies to engage in a coordinated approach to best address the challenges on how to meet the elimination target."

This comes after Merck Serono launched its new Oncology Partnership and Education Network earlier this year, which aims to improve patient outcomes in metastatic colorectal cancer.ADNFCR-8000103-ID-801722700-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.